![]() |
VM BioPharma Announces Publication of Phase 1/2 Clinical Data of Novel Gene Therapy V
VM BioPharma Announces Publication of Phase 1/2 Clinical Data of Novel Gene Therapy VM202 in Amyotrophic Lateral Sclerosis (ALS)
VM BioPharma Announces Publication of Phase 1/2 Clinical Data of Novel Gene Therapy VM2 2 in Amyotrophic Lateral Sclerosis (ALS) - News Press Release | PharmiWeb.com |
All times are GMT -5. The time now is 04:19 PM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.